Introduction {#s1}
============

Adenosine receptors belong to the GPCR family and have been classified on the basis of their molecular, biochemical, and pharmacological properties in four subtypes that are broadly distributed among different tissues including brain. The adenosine A~2A~ receptor is a G~s~ coupled receptor (Kull et al., [@B19]; Vu, [@B40]) that modulates cAMP production mediated by adenylyl cyclase activation upon ligand binding. A~2A~ receptors are particularly abundant in the basal ganglia and exhibit a somato-dendritic localization in GABAergic enkephalinergic neurons of the striatum (Schiffmann et al., [@B35]). However, they can also be found in several other brain regions including the olfactory bulb and hippocampus (Sebastião and Ribeiro, [@B37]). The current understanding of the role of A~2A~ receptors in the brain emphasizes their ability to interact with GPCRs of other neuromodulatory or neurotransmitter systems, and to provide a fine tuning of neuronal activity (Sebastião and Ribeiro, [@B37]). A~2A~ receptors mostly exist as either homodimers or heteromers (Canals et al., [@B5]; Sebastião and Ribeiro, [@B37]). A~2A~ receptor activation facilitates opioid and CB~1~ receptor signaling in the striatum (Carriba et al., [@B7]; Sebastião and Ribeiro, [@B37]) and heterodimerization with the metabotropic glutamate receptor mGluR5 has a synergistic effect at the level of adenylate cyclase and MAPK activation upon A~2A~ and mGluR5 receptor co-stimulation (Ferré et al., [@B11]; Nishi et al., [@B32]). The most studied receptor heteromer, however, is the heteromer of adenosine A~2A~ and dopamine D~2~ receptor, where A~2A~ receptors counteract D~2~ receptor activation (Ferré et al., [@B12]; Navarro et al., [@B30]).

We have previously reported the Ca^2+^-mediated modulation of the quaternary structure and function of A~2A~-D~2~ receptor heteromers (Navarro et al., [@B30]). Calmodulin (CaM) transduces a local change in Ca^2+^ concentrations to the receptor heteromer function via direct binding to the carboxy terminus of the A~2A~ receptor in a A~2A~-D~2~ receptor heteromer, modulating thereby MAPK signaling upon agonist stimulation in a Ca^2+^-dependent manner (Navarro et al., [@B30]). The fine-tuning of other GPCRs via Ca^2+^/CaM interaction has been studied already in some detail (for review see Ferré et al., [@B13]; Mikhaylova et al., [@B24]). Interestingly, the third intracellular loop of many GPCRs is not only participating in binding of G proteins but also represents a motif that is predicted to bind CaM. Indeed CaM can interact in a Ca^2+^-sensitive manner with dopamine D~2~, μ opioid, muscarinergic, and other receptors (Ritter and Hall, [@B33]; Ferré et al., [@B13]). The functional consequences of the CaM interaction with GPCRs frequently include an attenuation of G protein coupling (Nickols et al., [@B31]; Ritter and Hall, [@B33]). Interaction of CaM with the carboxy-terminus has been demonstrated not only for the adenosine A~2A~ receptor but for metabotropic glutamate receptors (mGluR5 and mGluR7) as well (Minakami et al., [@B27]; Nakajima et al., [@B29]; Ferré et al., [@B13]). However, interaction and modulation of GPCRs signaling is not an exclusive feature of CaM. Other calcium binding proteins from the CaM superfamily have been shown to interact with GPCRs directly or can attenuate receptor desensitization via association with the particular G protein-coupled receptor kinases (GRKs/Kabbani et al., [@B17]; Komolov et al., [@B18]). One of the classical examples is the interaction between the dopamine D~2~ receptor and NCS-1 where binding of NCS-1 to the cytoplasmic tail of the D~2~ receptor inhibits its phosphorylation and subsequent internalization after ligand binding (Kabbani et al., [@B17]). Therefore, it is conceivable that other calcium binding proteins from the CaM superfamily could also specifically interact with certain GPCRs. Evolutionary and historically the neuronal members of the CaM superfamily are divided into two large groups named neuronal calcium sensor proteins (NCS) and neuronal Calcium Binding proteins (nCaBPs/Mikhaylova et al., [@B24]). Both groups resemble the structure of their common ancestor (CaM) with four EF-hand Ca^2+^-binding motifs. However, not all EF-hands are able to bind Ca^2+^ ions although they still might be involved in protein-protein interactions. In the current study we aimed to investigate whether one of the most abundant and widely distributed members of the NCS group---NCS-1 (Burgoyne, [@B4]; Mikhaylova et al., [@B24]) and the founding member of the nCaBP group---caldendrin (Seidenbecher et al., [@B39]) are able to associate with the adenosine A~2A~ receptor. All three proteins have overlap in their expression profiles and can be found in the same brain regions and the same type of neurons (Sebastião and Ribeiro, [@B36]; Martone et al., [@B22]; Laube et al., [@B20]; Bernstein et al., [@B3]; Rosin et al., [@B34]). To address this issue we implemented bioluminescence resonance energy transfer (BRET) and co-immunoprecipitation approaches and checked the functional role of the interaction by A~2A~ receptor agonist induced MAPK and AKT signaling in co-transfected HEK293 cells.

Materials and methods {#s2}
=====================

cDNA constructs and antibodies
------------------------------

cDNA constructs encoding human adenosine A~2A~ receptor (A~2A~ in pEYFP-N1, A~2A~ in pRluc-N1, and A~2A~ in pGFP-2-N1 vectors) or human dopamine D~2~ receptor and CaM in pEYFP-N1 vector, were previously described (Navarro et al., [@B30]). NCS-1 in pEYFP-N1 vector was published previously (Zhao et al., [@B43]). NCS-1 in pTagRFP-N or pEGFP-N1 vectors was subcloned from the pNCS-1-YFP-N1 plasmid using XhoI and BamHI restriction sites. Caldendrin was subcloned from a caldendrin-EGFP-N1 plasmid (Dieterich et al., [@B10]) into a pEYFP-N1 vector using EcoRI and BamHI restriction sites. The identity of the newly cloned construct was confirmed by sequencing analysis. pEGFP-N1 (Clontech), pTagRFP-N (Evrogen, Moscow, Russia), and pcDNA3.1 (Invitrogen, Darmstadt, Germany) were used as a corresponding negative controls for co-immunoprecipitation experiments and in surface biotinylation studies.

The following primary antibodies were used: Anti-NCS-1 rabbit (Santa Cruz Biotechnology, Heidelberg, Germany), anti-GFP mouse (MMS-118R, HiSS Diagnostics, Freiburg, Germany), anti-Renilla Luciferase mouse (Millipore, Schwalbach, Germany), anti-phospho-ERK1/2 mouse (Sigma-Aldrich, Madrid, Spain), anti-ERK1/2 rabbit (Sigma-Aldrich, Madrid, Spain), and anti-phospho-AKT rabbit (SAB Signalway antibody, Madrid, Spain). The secondary antibodies were: goat anti-mouse immunoglobulins HRP conjugated (P0447, Dako, Hamburg, Germany), goat anti-rabbit IgG HRP conjugated (\#7074, Cell Signaling, Frankfurt am Main, Germany), peroxidase-AffiniPure goat anti-mouse IgG, light chain^\*^ specific antibody (Jackson ImmunoResearch) and Alexa Fluor 568 goat anti-rabbit IgG (A11031, A11036, Invitrogen, Darmstadt, Germany).

Cell culture and transient transfection
---------------------------------------

HEK293, HEK-293T cells, and COS-7 cells were grown in Dulbecco\'s modified Eagle\'s medium (DMEM) supplemented with 2 mM L-glutamine, 100 U/ml penicillin/streptomycin, and 5% (v/v) heat inactivated Fetal Bovine Serum (FBS) (Invitrogen, Paisley, Scotland, UK). For immunocytochemistry experiments HEK-293 and COS-7 cells were plated on 18 mm coverslips, grown for 24 h and then transfected with Lipofectamine 2000 (Invitrogen, Karlsruhe, Germany) according to the manufacturer\'s protocol. Twenty-four hours after transfection the cells were fixed with 4% paraformaldehyde (PFA) and processed for immunostaining as described below. For surface biotinylation experiments HEK293T cells were grown in 75 cm^2^ culture flasks and transfected with Polyfect (Qiagen) according to the manufacturer\'s protocol. HEK-293T cells for BRET experiments were transfected with the plasmids encoding CaM, NCS-1, caldendrin, and adenosine A~2A~ receptor fusion proteins by PEI (PolyEthylenImine, Sigma, Steinheim, Germany) as previously described (Carriba et al., [@B6]).

Immunocytochemistry, laser scanning microscopy, and image analysis
------------------------------------------------------------------

Coverslips with transfected HEK-293 and COS-7 were fixed with 4% PFA for 10 min at 37°C, extensively washed with PBS and immunostained for endogenous NCS-1 as described before (Mikhaylova et al., [@B25]) with anti-NCS-1 rabbit antibody in a dilution of 1:300. COS-7 cells transfected with A~2A~-Rluc construct were stained with anti-Renilla Luciferase mouse antibody in dilution 1:500. F-actin was stained with Alexa Fluor 568 phalloidin (Molecular probes, Life Technologies, Darmstadt, Germany) diluted in 1:1000 in PBS and incubated for 10 min at room temperature. Fluorescence images were obtained on a TCS SP5 II confocal laser scanning microscope (Leica, Germany) using a 63× oil objective and zoom factors in the range of 1--4×. A 405 laser line was used for visualizing DAPI staining, 488 for GFP/YFP, 568 for the Alexa 568, and TagRFP. Images were acquired as *z*-stacks with 0.3 μm *z*-step. Maximum projections of *z*-stack were created in the ImageJ program (ImageJ, NIH).

BRET assays
-----------

HEK-293T cells were grown in six-well plates till about 60% confluence and then were transiently co-transfected with a constant amount of cDNA encoding for Rluc fusion protein and with increasing amounts of cDNA, corresponding to the protein fused to YFP. Two hours before quantifying fluorescence intensity, the supplemented medium (DMEM) was replaced by HBSS in the presence (1.26 mM) or in the absence of Ca^2+^. Cells supplemented with Ca^2+^ were treated with 1 μm of ionomycin 10 min prior to the fluorescence measurements. To quantify protein-YFP expression, cells (20 μg protein) were distributed in 96-well microplates (black plates with a transparent bottom), and fluorescence was read in a Mithras LB 940 using an excitation filter at 400 nm. Protein-fluorescence expression was determined as fluorescence of the sample minus the fluorescence of cells expressing the BRET donor alone. For BRET measurements, cell suspensions (20 μg protein) were distributed in 96-well microplates (Corning 3600, white plates; Sigma) and 5 μM coelenterazine H (Molecular Probes, Eugene, OR) was added. After 1 min, the readings were collected using a Mithras LB 940 that allows the integration of the signals detected in the short-wavelength filter at 485 nm (440--500 nm) and the long-wavelength filter at 530 nm (510--590 nm). To quantify protein-Rluc luminescence readings were also collected after 10 min of adding coelenterazine H. The net BRET is defined as \[(long-wavelength emission)/(short-wavelength emission)\]-Cf where Cf corresponds to \[(long-wavelength emission)/(short-wavelength emission)\] for the donor construct expressed alone in the same experiment. BRET is expressed as mili BRET units (mBU) determined as net BRET × 1000. A hyperbolic saturation curve showing an increase in BRET signal as a function of the acceptor fusion protein expression (acceptor protein expression relative to the donor protein expression, YFP/Rluc) is indicative of a specific interaction between the receptor-Rluc and Ca^2+^ sensor-YFP fusion constructs (Ayoub and Pfleger, [@B2]). BRET curves were fitted by using a non-linear regression equation, assuming a single phase with GraphPad Prism software (San Diego, CA, USA) to obtain the BRET~max~ and BRET~50~ values. The BRET~50~ parameter represents the acceptor/donor ratio giving 50% of the BRET~max~ and was used to estimate the relative affinity of the interaction. BRET data are expressed as means ± S.E.M. of 4--6 different experiments grouped as a function of the amount of BRET acceptor. Statistical differences in BRET parameters were analyzed with bifactorial ANOVA followed by *post-hoc* Bonferroni\'s tests (*p* = 0.05).

Co-immunoprecipitation assay (Co-IP) and immunoblotting
-------------------------------------------------------

Heterologous Co-IP was performed with extracts from HEK293T cells transiently expressing A~2A~-YFP, D~2~-YFP, GFP, and NCS-1-tagRFP. Endogenous NCS-1 was co-immunoprecipitated from HEK293T cells transfected only with A~2A~-YFP or GFP plasmids. YFP-tagged receptors and GFP control were immunoprecipitated for 12 h at 4°C with anti-GFP mouse antibody coupled to magnetic beads. Purification of antibody bound complexes was done using the μMACS™ GFP Isolation Kit (Miltenyi Biotec GmbH, Germany) according to the protocols supplied by manufactures, except that six washing steps were introduced to remove the unspecific binding to the beads. Another set of experiments was performed for A~2A~-YFP and GFP with overexpressed NCS-1-TagRFP. Extraction of proteins from HEK293T cells was done as described previously (Hradsky et al., [@B15]). NCS-1 was immunoprecipitated with anti-NCS-1 rabbit antibody coupled to Protein G sepharose (GE Healthcare) or corresponding rabbit IgG controls overnight at 4°C. In both cases, high Ca^2+^ and Ca^2+^-free conditions were achieved by addition of 0.5 mM of Ca^2+^ and 1 mM of Mg^2+^ or 2 mM EGTA and 1 mM Mg^2+^, respectively, to the cell extracts during immunoprecipitation as well as into the washing buffers. Beads with precipitated protein complexes were washed three times with corresponding extraction buffers and eluted with 2× SDS sample buffer. Eluted samples were checked on SDS-PAGE/WB using anti-NCS-1 and anti-GFP antibody. To measure the effect of Ca^2+^ on the efficiency of co-immunoprecipitation, the total amount of A~2A~ receptor co-purified at different conditions was quantified using the "Gel Analyzer" plug-in provided in the ImageJ software (NIH, USA). The maximal binding observed with anti-NCS-1 antibody in the presence of Ca^2+^ was taken as 100% for each experiment individually and % deviations from this condition were measured for the other groups. Confidence interval was calculated and data were represented as averages of 4--5 independent experiments ± standard error mean (S.E.M).

Surface biotinylation assay
---------------------------

HEK293T cells overexpressing A~2A~-YFP alone or together with NCS-1-TagRFP and GFP control co-transfected with NCS-1-TagRFP were grown for 48 h in supplemented DMEM. Then growth medium was removed, cells were washed twice with HBSS and serum-free DMEM was added for another 2 h. Cells were labeled with Sulfo-NHS-SS-Biotin (Pierce) for 15 min at 4°C according to the manufacturers manual. Unbound biotin was sequestered and cells were harvested by scrapping, proteins were extracted with 1× TBS containing 1% Triton-X-100 over 1 h at 4°C. Equal amounts of extract were bound to Streptavidin beads (Life Technologies) and biotinylated proteins were eluted with 2× SDS and subjected to SDS-PAGE. A~2A~-YFP protein bands were detected with anti-GFP mouse antibody. NCS-1-TagRFP was visualized with anti-NCS-1 rabbit antibody on the same membrane. The efficiency of surface biotinylation for A~2A~--YFP in the presence or absence of NCS-1-TagRFP (*n* = 4) was quantified by measuring the optical densities of GFP signal as described above. Obtained values were compared between groups with and without overexpressed NCS-1 (the later one is taken as 100%). Statistical comparison was done with bifactorial ANOVA followed by *post-hoc* Bonferroni\'s tests.

MAPK and AKT phosphorylation assays
-----------------------------------

A detailed protocol for activation of adenosine A~2A~ receptors in HEK293T cells by addition of the A~2A~ receptor agonist CGS21680 (100 nM) has been described previously (Navarro et al., [@B30]). Briefly, HEK293T cells expressing A~2A~ and NCS-1 or the corresponding controls were grown in 25 cm^2^ flasks to 50% confluence and cultured in serum-free medium overnight before the experiment. Two hours before the experiment, the cells medium was changed to HBSS buffer containing 1.26 mM Ca^2+^ and cells were treated or not with 1 μM ionomycin for 5 min before the addition of CGS21680. After cell lysis and estimation of protein concentration equal amounts of each sample (10 μg) were subjected to SDS-PAGE. To determine the level of ERK1/2 and pAKT phosphorylation, the membranes were then probed with a mouse anti-phospho-ERK1/2 antibody or phospho-AKT antibody. Total-ERK1/2 antibody was used as a loading control. The levels of phosphorylated ERK1/2 and phosphorylated AKT were normalized for differences in loading using the total ERK1/2 protein bands. Quantitative analysis of detected bands was performed by Odyssey V3.0 software. Statistical comparison was done with bifactorial ANOVA followed by *post-hoc* Bonferroni\'s tests (^\*^*p* = 0.05).

Results {#s3}
=======

Molecular interactions between adenosine A~2A~ receptor and calcium sensor proteins in living cells
---------------------------------------------------------------------------------------------------

The BRET technique can be successfully used as a method to test a protein---protein interaction in living cells (De and Gambhir, [@B9]; Carriba et al., [@B6]). Particularly, previously reported direct binding between the carboxy terminus of the A~2A~ receptor and CaM (Woods et al., [@B41]) was verified and extensively characterized using BRET (Navarro et al., [@B30]). This method is based on the fact that a luminescent donor (Rluc) oxidates the substrate coelenterazine H emitting bioluminescence that can be transferred to a fluorescent acceptor (YFP) when the distance between the donor and the acceptor is about 4.4 nm, (Dacres et al., [@B8])---a typical distance between proteins interacting in a macro complex. The advantage of the BRET technique over classical techniques like co-immunoprecipitation is that it is performed in living cells and the protein concentrations of each protein can be carefully controlled with the interaction monitored over a range of protein concentrations and ratios. We have chosen BRET to test if the A~2A~ receptor is capable of forming a complex with other members of the CaM superfamily, namely NCS-1 and caldendrin. We compared the BRET efficiency between HEK293T cells co-expressing A~2A~ fused to *Renilla luciferase* (Rluc) and CaM, NCS-1 or caldendrin fused to YFP (Figures [1A--C](#F1){ref-type="fig"}). In agreement with our previous findings, the saturation curve obtained upon increasing CaM-YFP expression, indicated a specific interaction between CaM and A~2A~ (BRET~max~ 60 ± 7 mBU and BRET~50~ 41 ± 6). BRET occurred already at resting conditions but BRET~max~ was increased (*p* = 0.05) after 10 min of stimulation with 1 μM of ionomycin (BRET~max~ 78 ± 7 and BRET~50~ 48 ± 8/Figure [1A](#F1){ref-type="fig"}). Interestingly, a clear and saturable BRET signal was also observed when increasing amounts of NCS-1-YFP were co-expressed with a constant amount of A~2A~-Rluc (BRET~max~ 43 ± 4 mBU and BRET~50~ 11 ± 5, Figure [1B](#F1){ref-type="fig"}) again demonstrating a specific interaction. Elevation of intracellular Ca^2+^ concentration by preincubation of HEK293T cells with ionomycin (1 μM) for 10 min, increased (*p* = 0.05) both BRET~max~ (57 ± 6 mBU) and BRET~50~ (33 ± 9/Figure [1B](#F1){ref-type="fig"}). These results can be interpreted in two ways, neither of which is exclusive of the other. In one, Ca^2+^ led to conformational changes in the A~2A~-NCS-1 complex that reduces the distance between Rluc and YFP fused to the C-terminal domain of the two interacting fusion proteins. In the other, Ca^2+^ increases complex formation by increasing the affinity between the two proteins.

![**Adenosine A~2A~ receptors interact with calmodulin and NCS-1 but not with caldendrin.** BRET measurements were performed in HEK-293T cells co-transfected with 0.2 μg cDNA corresponding to the donor A~2A~-Rluc and increasing amounts of the cDNA (0.1--2 μg) corresponding to CaM-YFP **(A)**, NCS-1-YFP **(B)** or caldendrin-YFP **(C).** In **A** and **B** a clear BRET saturation curves were seen. Both interactions occur at basal Ca^2+^ levels (black curve) but can be facilitated in the presence of Ca^2+^/ionomycin (red curve). No positive BRET interaction was seen for A~2A~-Rluc and caldendrin-YFP at either Ca^2+^ concentrations **(C)**. Both fluorescence and luminescence of each sample were measured before every experiment to confirm similar donor expression (approximately 100,000 bioluminescence units) while monitoring the increase in acceptor expression (1000--35,000 fluorescence units). The relative amount of BRET is given as a function of 100× the ratio between the fluorescence of the acceptor (YFP) and the luciferase activity of the donor (Rluc). Average of 5--6 independent experiments measured in triplicates are plotted as mean value ± S.E.M. At the top images a schematic representation of BRET is given.](fnmol-05-00053-g0001){#F1}

Next we investigated if A~2A~ and caldendrin can form heteromers. A non-specific (linear) and low BRET signal was obtained in this case, a result consistent with two proteins not interacting (Figure [1C](#F1){ref-type="fig"}). An increase in intracellular Ca^2+^ levels had no effect on BRET efficiency either. Taken together these results suggest that caldendrin might not be an interaction partner of the A~2A~ receptor and that not all EF-hand proteins produce a BRET signal indicative of an interaction.

To get more insight in this, we performed co-immunoprecipitation experiments with transfected HEK293T cells. Interestingly, we found that NCS-1 is expressed endogenously in this cell line (Figures [2A,B](#F2){ref-type="fig"}). Immunostaining with anti-NCS-1 antibody showed an extranuclear punctate pattern as expected for a N-terminal myristoylated protein that exhibits membrane localization. The co-localization between endogenous NCS-1 and overexpressed A~2A~-YFP was mostly restricted to the cell periphery (Figure [2A](#F2){ref-type="fig"}). We then performed co-immunoprecipitation experiments with HEK293T cells co-transfected with A~2A~-YFP and NCS-1-TagRFP or the corresponding control contructs (Figure [2C](#F2){ref-type="fig"}). Dopamine D~2~ receptor (D~2~-YFP) was included as a positive control since its interaction with NCS-1 is well established (Kabbani et al., [@B17]; Lian et al., [@B21]). The mouse anti-GFP antibody led to immunoprecipitation of receptor-YFP in complex with overexpressed (Figure [2C](#F2){ref-type="fig"}) or endogenous (Figure [2D](#F2){ref-type="fig"}) NCS-1. In the case of overexpression, the binding of NCS-1 to D~2~ and A~2A~ receptors already occurred in the presence of EGTA (Figure [2C](#F2){ref-type="fig"}). Immunoprecipitation of overexpressed and endogenous NCS-1 with rabbit anti-NCS-1 bound to Protein G sepharose have shown that A~2A~-YFP was efficiently co-purified with NCS-1-TagRFP (Figure [2E](#F2){ref-type="fig"}). The corresponding controls with unspecific rabbit IgG showed again some unspecific binding of N-myristoylated NCS-1 to the beads but it was significantly lower as compared to immunoprecipitations done with the anti-NCS-1 antibody (Figures [2E,F](#F2){ref-type="fig"}). Interestingly, analogous to the BRET experiments the presence Ca^2+^ had a positive effect on the interaction (Figures [2D,E](#F2){ref-type="fig"} and [F](#F2){ref-type="fig"}) and mostly a homomeric A~2A~-YFP receptor formed a complex with NCS-1 (Figure [2E](#F2){ref-type="fig"}).

![**Adenosine A~2A~ receptors form a complex with endogenous and the overexpressed NCS-1 in co-immunoprecipitation experiments.** HEK293 cells express endogenous NCS-1 **(A)** that shows partial co-localization with overexpressed adenosine A~2A~ receptor at the plasma membrane of transfected cells (low panel, white arrows indicate the co-localizing spots). **(B)** HEK293T cell transfected with NCS-1-TagRFP or Tag-RFP probed with anti-NCS-1 rabbit antibody. NCS-1-TagRFP band can bee seen in the range of 45 kDa. Note a weak 18 kDa band of endogenous NCS-1 present in both samples. Additional band about 25 kDa in the first lane could be a degradation product of NCS-1-TagRFP. **(C)** Overexpressed A~2A~-YFP and NCS-1-TagRFP can be co-immunoprecipitated from HEK293T cell extract. Dopamine D~2~ receptor with YFP-tag is included as a positive control. YFP-fused receptors or GFP control were detected with anti-GFP mouse antibody, detection of NCS-1-TagRFP was done with anti-NCS-1 rabbit antibody. **(D)** Endogenous NCS-1 is co-immunoprecipitated with A~2A~-YFP from HEK293T cell extract. **(E)** Immunoprecipitation (IP) is performed with anti-NCS-1 rabbit antibody. Anti-NCS-1 antibody show positive immunoprecipitation of the antigene (low panel). Note, that there is endogenous NCS-1 expressed in HEK293 cells but at much lower levels then overexpressed NCS-1. Mostly a homomeric form of A~2A~-YFP is detected with anti-GFP mouse antibody (upper panel). **(F)** The binding of A~2A~ receptor to NCS-1 is enhanced in the presence of Ca^2+^. Quantification of immunoprecipitated A2A-YFP. Data represented as average of 4--5 independent experiments ± SEM.](fnmol-05-00053-g0002){#F2}

Overexpression of NCS-1 has no impact on surface expression of the A~2A~ receptor in non-stimulated cells
---------------------------------------------------------------------------------------------------------

NCS-1 is involved in regulation of vesicular trafficking from the trans-Golgi network (TGN) to the plasma membrane and associates with the Golgi membranes via its N-terminal myristoyl tail where it regulates activity of phosphatidylinositol 4-kinase IIIβ (PI-4KIIIβ), thus providing a Ca^2+^-dependent control for the regulated local synthesis of phosphatidylinositol 4-phosphate (PI(4)P) and for the exit of vesicles from TGN (Zhao et al., [@B43]; Haynes et al., [@B14]; Mikhaylova et al., [@B25]). At the plasma membrane NCS-1 is involved in transduction of Ca^2+^ signaling and regulating the activity of different kinases and surface receptors (for review see Mikhaylova et al., [@B24]). A~2A~ receptor traverses the secretory trafficking pathway from the ER to the Golgi complex on the way to the plasma membrane. Therefore, we next asked how the presence of NCS-1 would affect the expression of A~2A~ receptor at the plasma membrane and where in the cell the complex of A~2A~ receptor and NCS-1 might occur. To address the first question, we performed a quantitative surface biotinylation assay to compare the surface expression of A~2A~ receptor with and without co-transfection of NCS-1. Two major bands corresponding to the monomer and the dimer of A~2A~ receptor were biotinylated and purified with streptavidin beads (Figure [3A](#F3){ref-type="fig"}). Additional bands appearing in streptavidin-bound fraction but not in whole-cell extract might represent a differentially modified (for example glycosilated, phosphorylated, etc.) plasma membrane receptor fraction. Although there we observed a slight increase in immunoreactivity of biotinylated A~2A~ when co-expressed with NCS-1, we have not found any significant effect on surface receptor expression in non-stimulated HEK293T cells (Figure [3B](#F3){ref-type="fig"}). Next, for the co-localization study we have chosen COS-7 cells because they are significantly larger than HEK293T cells. After 24 h of overexpression, significant amounts of A~2A~-YFP fluorescence was still associated with the ER and the Golgi membranes. Considerable overlap of A~2A~-YFP and NCS-1-TagRFP fluorescence, however, was mostly seen close to the plasma membrane compartment (Figure [3C](#F3){ref-type="fig"}). Therefore, in another set of experiments we included phalloidin-568 staining to visualize a dense cortical actin cytoskeleton along the cell membranes. Additionally, since the excitation/emission spectrum of TagRFP is largely overlapping with Alexa Fluor 568, we replaced the fusion constructs by NCS-1-YFP and A~2A~-Rluc (Figure [3D](#F3){ref-type="fig"}). Again we could see a co-localization of A~2A~ and NCS-1 fluorescence overlapping with F-actin at the edges of the cell membrane as well as in small clusters in the cytosol (Figure [3D](#F3){ref-type="fig"}). These clusters could represent post-Golgi transport carriers, endosomes or some other vesicular compartments.

![**NCS-1 does not interfere with the trafficking and surface expression of adenosine A~2A~ receptors in the basal conditions (no agonist stimulation). (A)** HEK293T cells overexpressing A~2A~-YFP alone or together with NCS-1-TagRFP and GFP control co-transfected with NCS-1-TagRFP were labeled with Sulfo-NHS-SS-Biotin for 15 min at 4°C and biotinylated proteins were purified with Streptavidin beads. Detection was done with anti-GFP and anti-NCS-1 antibody. Note the SDS-resistant dimer of A~2A~-YFP. NCS-1-TagRFP is also co-purified with surface biotinylated proteins suggesting that there might be another binding partner of NCS-1 endogenously expressing in HEK293T cells. **(B)** Although there are slight differences in amount of surface labeled A~2A~-YFP between TagRFP and NCS-1-TagRFP expressing cells, no clear effect of NCS-1 overexpression can be seen. **(C)** Confocal image of a COS-7 cell co-expressing with A~2A~-YFP and NCS-1-TagRFP for 24 h shows co-localization of both proteins at the cell periphery (white arrows indicate co-localization). **(D)** A2A-Rluc co-localizes with NCS-1-YFP and cortical F-actin along the plasma membrane of transfected COS-7 cells. Note the intracellular vesicular structures showing overlapping fluorescence of A2A and NCS-1.](fnmol-05-00053-g0003){#F3}

Binding of NCS-1 to the A~2A~ receptor dimer has a differential effect on agonist-induced intracellular signaling
-----------------------------------------------------------------------------------------------------------------

Homodimers of adenosine A~2A~ receptor are the predominant form of the receptor at the cell membrane (Canals et al., [@B5]). Moreover, based on the co-immunprecipitation data, where mostly the homomeric form of A~2A~ was co-purified with NCS-1, we questioned if NCS-1 could interact with the A~2A~ homodimer. We performed BRET saturation curves in HEK293T cells expressing an A~2A~-Rluc and increasing amounts of A~2A~-YFP in the presence or absence of NCS-1 (Figure [4A](#F4){ref-type="fig"}). The presence of NCS-1 modified the BRET~max~ (*p* = 0.01) and BRET~50~ (*p* = 0.05) corresponding to the formation of a A~2A~ homodimer (BRET~max~ 196 ± 10 mBU and BRET~50~ 63 ± 7 in the absence of NCS-1; BRET~max~ 131 ± 9 mBU and BRET~50~ 90 ± 10 in the presence of NCS-1). This result demonstrates that NCS-1 interacts with A~2A~ receptor homodimers and induces changes in their quaternary structure in a manner that suggests a greater distance between donor and acceptor, a change in orientation, and/or a diminished number of heteromers. Another possibility that we cannot exclude would be a change in the density of adenosine A~2A~ receptors at the plasma membrane upon overexpression of NCS-1. However, we have not found significant increases in the amount of A~2A~ receptor associated with the plasma membrane using surface biotinylation assay (Figure [3A](#F3){ref-type="fig"}). BRET experiments were always carried out at constant amounts of receptors between compared groups. Since we performed our study in intact HEK293T cells, a small change in plasma membrane density of A~2A~ receptors would presumably be compensated for by a change in density in other intracellular membranes. Thus, the changes measured in the BRET assay are most likely due to differences in receptor-receptor interaction. An elevation in Ca^2+^ levels by treating cells with ionomycin (1 μM) did not modify A~2A~--A~2A~ homomerization but modified the BRET~50~ (*p* = 0.05) in the presence of NCS-1 (BRET~max~ 148 ± 10 mBU and BRET~50~ 48 ± 7), indicating a change in the receptor association between NCS-1 and the A~2A~ heteromer in the presence of Ca^2+^ (Figure [4A](#F4){ref-type="fig"}).

![**NCS-1 associates with a A~2A~--A~2A~ homodimer and modulates the adenosine A~2A~ receptor signaling in a Ca^2+^ dependent manner. (A)** BRET saturation curves were obtained from HEK-293T cells co-transfected with 0.2 μg cDNA corresponding to A~2A~-Rluc fusion protein and increasing amounts of cDNA (0.05--1 μg) corresponding to A~2A~-YFP fusion protein without (black and red curves) or with 0.5 μg of the cDNA corresponding to NCS-1 (green and blue curves). Measurements were done either at basal conditions (black and green curves) or after treatment of cells with 1 μM of ionomycin for 10 min (red and blue curves). Ca^2+^ has no effect on A~2A~ receptor homodimerization itself (red curve compared to the black one) but modifies A~2A~-A~2A~-NCS-1 heteromeric complex structure (blue curve compared to the green one). Both fluorescence and luminescence of each sample were measured before every experiment to confirm similar donor expression (approximately 100,000 bioluminescence units) while monitoring the increase in acceptor expression (1000--27,000 fluorescence units). The relative amount of BRET is given as a function of 100× the ratio between the fluorescence of the acceptor (YFP) and the luciferase activity of the donor (Rluc). Average of 5--6 independent experiments measured in triplicates are plotted as mean value ± S.E.M. A schematic representation of BRET is given at the top. In **(B)** and **(C)** HEK-293T cells transfected with 0.5 μg cDNA corresponding to adenosine A~2A~ receptor alone or with cDNA corresponding to caldendrin-YFP (0.8 μg) or NCS-1-YFP (0.6 μg) were stimulated with 100 nM of CGS 2168 at the basal condition, in the presence of 1.26 mM of Ca^2+^ in HBSS buffer or in the presence of both 1.26 mM of Ca^2+^ and 1 μM of Ca^2+^ ionophore ionomycin. Equal amount of protein were analyzed by SDS-PAGE using phospho-ERK1/2 **(B)** or phospho-AKT **(C)** and total-ERK1/2 antibodies. Quantification of eight independent experiments indicates stimulatory effect on NCS-1 on MAPK signaling **(B)** or pAKT levels **(C)** at the basal Ca^2+^ conditions. ^\*^*p* = 0.05.](fnmol-05-00053-g0004){#F4}

The adenosine A~2A~ receptor is a G~s~ coupled receptor that regulates cAMP production. The activation of the A~2A~ receptor regulates a number of protein and lipid kinases, including MAPK 1-3 (ERK1/2) phosphorylation and activity (Wyatt et al., [@B42]; Navarro et al., [@B30]) and V-akt murine thymoma viral oncogene homolog 1 (AKT, also called PKB/Mori et al., [@B28]). To test the effect of NCS-1 overexpression on A~2A~ receptor function we analyzed MAPK and AKT signaling pathways. 2-\[p-(2-carboxyethyl)phenylethylamino\]-50 ethylcarboxamidoadenosine (CGS 21680) is a selective agonist of A~2A~ type of adenosine receptors. CGS21680-induced ERK1/2 and AKT phosphorylation was assessed in transiently transfected HEK293T cells at basal conditions or at elevated calcium levels. Agonist stimulation of A~2A~ in NCS-1-YFP transfected cells induced a significant increase in ERK1/2 phosphorylation at basal conditions and this effect was reversed when cells were pre-treated with Ca^2+^/Ionomycin (Figure [4B](#F4){ref-type="fig"}). As a negative control, overexpression of caldendrin-YFP, that showed no interaction with A~2A~ receptors, had no effect on ERK1/2 activity at any condition tested, demonstrating further the specificity of the NCS-1-induced effects (Figure [4B](#F4){ref-type="fig"}). Finally, NCS-1 promoted the CGS21680-induced AKT phosphorylation at resting Ca^2+^ levels and again this effect was blocked when intracellular Ca^2+^ concentrations were increased with ionomycin (Figure [4C](#F4){ref-type="fig"}).

Discussion {#s4}
==========

Adenosine receptors cross talk has been established with other GPCRs, ionotropic receptors, and receptor kinases to regulate their function with most of the characterized interactions occur via the A~2A~ receptor type (Sebastião and Ribeiro, [@B37]). Most important, the role of A~2A~ receptors in the brain is related to their ability to interact with other receptor systems (Sebastião and Ribeiro, [@B37]). Indeed, cross talk between the A~2A~ receptor and D~2~ type dopamine receptor, metabotropic glutamate receptor mGluR5 or endocanabinoid receptor CB~1~ in striatum modulates the signaling induced by these receptors and has important clinical implications for the treatment of Parkinson disease, schizophrenia, addiction, and potentially other brain disorders (Ferré et al., [@B11]; Carriba et al., [@B7]; Ferré et al., [@B12]).

Another level of complexity to the regulation of GPCRs signaling is added by cross talk between GPCRs system and intracellular Ca^2+^ signaling via CaM. Among a number of other GPCRs, CaM has been shown to bind to the carboxy-terminus adenosine A~2A~ receptors in a A~2A~-D~2~ receptor heteromer. Elevation of intracellular Ca^2+^ levels then triggers conformational changes in this complex via CaM providing a selective modulation of A~2A~-D~2~ receptor heteromer-mediated activation of the MAPK pathway (Navarro et al., [@B30]). Evolutionary and based on the history of their discovery, calcium sensors from the CaM superfamily that are particularly abundant in brain are divided into two larger groups named NCS and nCaBPs (Mikhaylova et al., [@B24]). Although CaM is ubiquitously expressed in all eukaryotic cells, emerging evidence supports a role for NCS and nCaBPs other than CaM in the regulation of a number of effectors. For example, there are interactions that are specific for particular calcium sensors (hippocalcin---PSD95; caldendrin---LC3/Seidenbecher et al., [@B38]; Dieterich et al., [@B10]; Jo et al., [@B16]) and that cannot be competed by CaM. Moreover, many CaM targets can interact with more than one NCS or nCaBPs. Voltage-gated Ca^2+^ channels (Ca~V~) (P/Q-, N-, and L-type), TRPC1/5 channels, GPCRs, IP3R, and PI-4KIIIβ are among them (for review see Mikhaylova et al., [@B24]). We have chosen two representative candidate proteins from each group of CaM-like calcium sensors. NCS-1 (also known as frequinin) is one of the first discovered and well-characterized NCS proteins. NCS-1, like other members of this family of proteins, has a widespread distribution in the brain and spinal cord (Martone et al., [@B22]). In terms of its structural organization, NCS-1 can associate with intracellular membranes via a N-terminal myristoyl tail and like CaM it has four EF-hand motifs where the first EF-hand is cryptic and does not coordinate Ca^2+^. Differently from CaM that displays a dumbbell conformation of the two EF-hand domains, NCS-1 exhibits a globular fold and NCS-1 can bind Ca^2+^ with higher affinity than CaM (in the range of 0.5--0.8 μM in Mg^2+^ bound form/Aravind et al., [@B1]; Mikhaylova et al., [@B25]). Ca^2+^ binding induces conformational changes and the exposure of hydrophobic surfaces for the interaction with the target protein or membrane. Caldendrin is the founding member of the nCaBP group of Ca^2+^ sensors (Seidenbecher et al., [@B39]). Most important, based on alignments of its carboxy terminal half that resembles the organization of CaM, caldendrin is the closest homolog of CaM in brain (Seidenbecher et al., [@B39]; Mikhaylova et al., [@B26], [@B24]; McCue et al., [@B23]).

To test if NCS-1 and caldendrin are able to interact with A~2A~ receptor in living cells we measured BRET between A~2A~---Rluc as the donor and calcium sensor---YFP as the acceptor. We observed a positive saturable signal only between A~2A~ and NCS-1 but not caldendrin. This result was surprising, as caldendrin is more closely related to CaM than NCS-1. Like CaM, binding of NCS-1 occurred already under basal Ca^2+^-conditions and was further facilitated by increased intracellular Ca^2+^ levels. We were able to confirm these data by heterologous co-immunoprecipitations from HEK293T cells transiently expressing A~2A~ or D~2~ receptors and NCS-1. These data suggest that NCS-1 is a novel interaction partner of A~2A~ receptor. Both proteins associate with membranes and can be found along the secretory trafficking pathway but mainly co-localize at the post-Golgi trafficking compartments including the cell membrane. Although there was a slight increase in the amount of surface receptor when cells were overexpressing NCS-1, this might be due to the stimulatory effect of NCS-1 on the activity of the Golgi localized enzyme PI-4KIIIβ but not likely due to trafficking of A~2A~ itself. Activation of PI-4KIIIβ leads to the increase in production of PI(4)P---rate limiting phosphoinositide in the TGN-to-plasma membrane trafficking (Zhao et al., [@B43]; Haynes et al., [@B14]; Mikhaylova et al., [@B25]) and would in general enhance the surface delivery of transmembrane proteins.

Using BRET we have found that NCS-1 is associated with a A~2A~ homodimer. More than 90% of A~2A~ overexpressed in HEK293T cells is functional only in dimeric form (Canals et al., [@B5]) and this indicates that NCS-1 associates with a functional A~2A~ receptor. Interestingly, in a recent paper of Lian and colleagues (2011) the NMR structure of Ca^2+^-bound NCS-1 and the dopamine D~2~ receptor binding peptide have indicated that monomeric NCS-1 can simultaneously bind two D~2~ receptors. Similarly, Ca^2+^ stabilizes a A~2A~-A~2A~-NCS-1 heteromeric complex. It is tempting to speculate, that this might relate to conformational changes in monomeric NCS-1 which induces conformational changes in the heteromer which then has differential consequences in terms of agonist-induced intracellular signaling. At basal conditions, stimulation with the A~2A~ receptor agonist CGS21680 had a positive effect on phosphorylation of ERK1/2 and AKT. In contrast, preincubation of cells with Ca^2+^/ionomycin reduced the agonist-induced ERK1/2 phosphorylation. Most important, this effect is specific for NCS-1 since overexpression of CaM had no effect on A~2A~ receptor homomer signaling but instead was important for A~2A~---D~2~ induced ERK1/2 phosphorylation (Navarro et al., [@B30]). The contribution of endogenous NCS-1 from HEK293 cells is probably very minor since the expression levels are quite low and we have not seen any change induced by elevated Ca^2+^ in the cells overexpressing only A~2A~ receptor alone.

In summary, in this study we provide the first evidence for a novel interaction between the adenosine A~2A~ receptor and NCS-1. We demonstrate that Ca^2+^ modulates both the association and the intracellular signaling in living cells and that this effect is specific for NCS-1 in the sense that caldendrin does not bind and that the association of CaM has different functional consequences. Understanding the role of NCS-1 in heteromerization of GPCRs will provide further insights on the function of GPCRs and might have potential clinical applications.
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